Corcept Therapeutics CORT
NASDAQ CORT
$111.62 -1.18 (-1.05%)
As of: Sep 4, 2026 · 3:59 PM EDT

Corcept Therapeutics (CORT) Tax Rate Growth (5y) (2022 - 2026)

Analysis

Corcept Therapeutics (CORT) Tax Rate Growth (5y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Corcept Therapeutics 11.76 Bn 11.46 Bn 252.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,084.00
Mar 31, 2026 4,715.00
Dec 31, 2025 -16,064.00
Sep 30, 2025 -4,369.00
Jun 30, 2025 -3,295.00
Mar 31, 2025 -13,690.00
Dec 31, 2024 -1,571.00
Sep 30, 2024 -1,250.00
Jun 30, 2024 -711.00
Mar 31, 2024 1,169.00
Dec 31, 2023 -44.00
Sep 30, 2023 -1,153.00
Jun 30, 2023 225.00
Mar 31, 2023 -389.00
Dec 31, 2022 38,091.00
Sep 30, 2022 -451.00
Jun 30, 2022 1,427.00
Mar 31, 2022 1,246.00